Ryan MacDonald
Stock Analyst at Needham
(0.04)
# 4,615
Out of 4,630 analysts
648
Total ratings
36.9%
Success rate
-11.1%
Average return
Main Sectors:
Stocks Rated by Ryan MacDonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: DCBO Docebo Inc. | Reiterated: Buy | $43.42 | $31.09 | +39.66% | 22 | Aug 7, 2026 | |
| NRDY Nerdy | Reiterated: Buy | $2 | $0.7561 | +164.52% | 26 | Aug 7, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $28 | $23.67 | +18.29% | 7 | Aug 7, 2026 | |
| CHGG Chegg | Reiterated: Hold | n/a | $0.9157 | - | 51 | Aug 6, 2026 | |
| DUOL Duolingo | Reiterated: Buy | $145 | $130.90 | +10.77% | 22 | Aug 6, 2026 | |
| AMWL American Well | Reiterated: Hold | n/a | $13.52 | - | 24 | Aug 5, 2026 | |
| HNGE Hinge Health | Reiterated: Buy | $76 → $97 | $89.33 | +8.59% | 8 | Aug 5, 2026 | |
| MH McGraw Hill | Reiterated: Buy | $19 | $11.60 | +63.79% | 8 | Aug 3, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $75 | $52.05 | +44.09% | 17 | Jul 31, 2026 | |
| TDOC Teladoc Health | Reiterated: Hold | n/a | $7.13 | - | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.81 | +72.12% | 37 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $24.23 | +36.19% | 4 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $12.80 | +25.00% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 | $230.47 | +17.15% | 31 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.12 | - | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $12.51 | +11.91% | 32 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $27 | $27.40 | -1.46% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $31.59 | +10.79% | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.6342 | +373.04% | 31 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7135 | - | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.62 | - | 38 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.22 | - | 10 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.73 | +74.52% | 30 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $25 | $26.64 | n/a | 32 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $214.94 | n/a | 22 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $83 | $65.77 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $92 | $262.13 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $20 | $8.67 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $500 | $210.45 | n/a | 18 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.87 | n/a | 17 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.33 | n/a | 12 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $147.02 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $165 | $265.21 | n/a | 4 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $78 → $86 | $179.64 | n/a | 5 | Feb 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $192.74 | n/a | 5 | Feb 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $499.99 | n/a | 5 | Jan 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $107 | $124.88 | n/a | 4 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 → $80 | $127.82 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $190 | $363.86 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $29.17 | n/a | 4 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $43 | $183.48 | n/a | 1 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.23 | n/a | 1 | Jul 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5.8 → $3 | $13.95 | n/a | 4 | Dec 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.5 | $12.04 | n/a | 1 | Mar 6, 2014 |
Docebo Inc.
Aug 7, 2026
Reiterated: Buy
Price Target: $43.42
Current: $31.09
Upside: +39.66%
Nerdy
Aug 7, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7561
Upside: +164.52%
Omada Health
Aug 7, 2026
Reiterated: Buy
Price Target: $28
Current: $23.67
Upside: +18.29%
Chegg
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.9157
Upside: -
Duolingo
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $130.90
Upside: +10.77%
American Well
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.52
Upside: -
Hinge Health
Aug 5, 2026
Reiterated: Buy
Price Target: $76 → $97
Current: $89.33
Upside: +8.59%
McGraw Hill
Aug 3, 2026
Reiterated: Buy
Price Target: $19
Current: $11.60
Upside: +63.79%
Tempus AI
Jul 31, 2026
Reiterated: Buy
Price Target: $75
Current: $52.05
Upside: +44.09%
Teladoc Health
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.13
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: $10
Current: $5.81
Upside: +72.12%
Jul 30, 2026
Reiterated: Buy
Price Target: $33
Current: $24.23
Upside: +36.19%
Jul 13, 2026
Maintained: Buy
Price Target: $16
Current: $12.80
Upside: +25.00%
Jun 4, 2026
Reiterated: Buy
Price Target: $270
Current: $230.47
Upside: +17.15%
Jun 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.12
Upside: -
May 28, 2026
Reiterated: Buy
Price Target: $14
Current: $12.51
Upside: +11.91%
May 14, 2026
Reiterated: Buy
Price Target: $55 → $27
Current: $27.40
Upside: -1.46%
May 12, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $31.59
Upside: +10.79%
May 12, 2026
Reiterated: Buy
Price Target: $3
Current: $0.6342
Upside: +373.04%
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.7135
Upside: -
Mar 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.62
Upside: -
Mar 9, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.22
Upside: -
Dec 9, 2025
Maintained: Buy
Price Target: $10
Current: $5.73
Upside: +74.52%
May 2, 2025
Maintained: Buy
Price Target: $43 → $25
Current: $26.64
Upside: n/a
Nov 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $214.94
Upside: n/a
Jun 20, 2023
Maintained: Buy
Price Target: $88 → $83
Current: $65.77
Upside: n/a
Jun 20, 2023
Maintained: Buy
Price Target: $84 → $92
Current: $262.13
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $11 → $20
Current: $8.67
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $500
Current: $210.45
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $45.87
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $7.33
Upside: n/a
Jun 22, 2017
Maintained: Hold
Price Target: $46
Current: $147.02
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $145 → $165
Current: $265.21
Upside: n/a
Feb 28, 2017
Reiterated: Hold
Price Target: $78 → $86
Current: $179.64
Upside: n/a
Feb 27, 2017
Maintained: Buy
Price Target: $101
Current: $192.74
Upside: n/a
Jan 27, 2017
Maintained: Buy
Price Target: $70 → $75
Current: $499.99
Upside: n/a
Jan 26, 2017
Maintained: Buy
Price Target: $95 → $107
Current: $124.88
Upside: n/a
Sep 13, 2016
Downgraded: Hold
Price Target: $95 → $80
Current: $127.82
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $190
Current: $363.86
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $29.17
Upside: n/a
Sep 13, 2016
Upgraded: Buy
Price Target: $43
Current: $183.48
Upside: n/a
Jul 7, 2016
Reiterated: Buy
Price Target: $50
Current: $7.23
Upside: n/a
Dec 26, 2014
Upgraded: Hold
Price Target: $5.8 → $3
Current: $13.95
Upside: n/a
Mar 6, 2014
Rated: Buy
Price Target: $1.5
Current: $12.04
Upside: n/a